Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2353-2366
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2353
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2353
Figure 5 Silencing of anti-silencing function 1B represses colorectal cancer tumorigenesis in mice.
A: Representative images of tumors in xenograft mice; B: The tumor volume in xenograft mice was monitored every 7 d and then the tumor growth curves of mice were constructed; C: Average tumor weight of xenograft mice was gauged; D: Protein levels of Ki67 and anti-silencing function 1B in tumor tissues of xenograft mice were determined by immunohistochemical staining. aP < 0.05, bP < 0.01, cP < 0.001. n = 5. ASF1B: Anti-silencing function 1B; NC: Negative control.
- Citation: Yu GH, Gong XF, Peng YY, Qian J. Anti-silencing function 1B knockdown suppresses the malignant phenotype of colorectal cancer by inactivating the phosphatidylinositol 3-kinase/AKT pathway. World J Gastrointest Oncol 2022; 14(12): 2353-2366
- URL: https://www.wjgnet.com/1948-5204/full/v14/i12/2353.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i12.2353